These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 24681836

  • 1. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
    Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G.
    Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
    [Abstract] [Full Text] [Related]

  • 2. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW, Bultink IE, Heslinga M, Voskuyl AE.
    Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
    [Abstract] [Full Text] [Related]

  • 3. Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
    Ruiz-Arruza I, Barbosa C, Ugarte A, Ruiz-Irastorza G.
    Autoimmun Rev; 2015 Oct; 14(10):875-9. PubMed ID: 26044819
    [Abstract] [Full Text] [Related]

  • 4. Damage in systemic lupus erythematosus and its association with corticosteroids.
    Zonana-Nacach A, Barr SG, Magder LS, Petri M.
    Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
    [Abstract] [Full Text] [Related]

  • 5. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study.
    Ruiz-Arruza I, Lozano J, Cabezas-Rodriguez I, Medina JA, Ugarte A, Erdozain JG, Ruiz-Irastorza G.
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):582-591. PubMed ID: 28704598
    [Abstract] [Full Text] [Related]

  • 6. It hasn't gone away: the problem of glucocorticoid use in lupus remains.
    Apostolopoulos D, Morand EF.
    Rheumatology (Oxford); 2017 Apr 01; 56(suppl_1):i114-i122. PubMed ID: 28013208
    [Abstract] [Full Text] [Related]

  • 7. Accrual of organ damage over time in patients with systemic lupus erythematosus.
    Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS.
    J Rheumatol; 2003 Sep 01; 30(9):1955-9. PubMed ID: 12966597
    [Abstract] [Full Text] [Related]

  • 8. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
    Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, Esposto A, García MA, Catoggio LJ, Cardiel MH, Barile LA, Amigo MC, Sato EI, Bonfa E, Borba E, Lavras Costallat LT, Neira OJ, Massardo L, Guibert-Toledano M, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.
    Lupus; 2019 Aug 01; 28(9):1101-1110. PubMed ID: 31291843
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroids in Lupus.
    Kasturi S, Sammaritano LR.
    Rheum Dis Clin North Am; 2016 Feb 01; 42(1):47-62, viii. PubMed ID: 26611550
    [Abstract] [Full Text] [Related]

  • 10. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C, Capdevila O, Espinosa G, Suárez S, Marín-Ballvé A, González-León R, Rodríguez-Carballeira M, Fonseca-Aizpuru E, Pinilla B, Pallarés L, Ruiz-Irastorza G, RELES, Autoimmune Diseases Study Group GEAS.
    Lupus; 2018 Dec 01; 27(14):2253-2261. PubMed ID: 30451641
    [Abstract] [Full Text] [Related]

  • 11. Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.
    Danza A, Graña D, Soto E, Silveira G, Carlomagno A, Rebella M.
    Lupus; 2022 Jun 01; 31(7):880-884. PubMed ID: 35354060
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for cataracts in systemic lupus erythematosus (SLE).
    Alderaan K, Sekicki V, Magder LS, Petri M.
    Rheumatol Int; 2015 Apr 01; 35(4):701-8. PubMed ID: 25257763
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M, Robeva R, Popivanov P.
    Clin Rheumatol; 2003 Oct 01; 22(4-5):318-23. PubMed ID: 14579164
    [Abstract] [Full Text] [Related]

  • 14. [A cross-sectional study on application of glucocorticoid in systemic lupus erythematosus patients].
    Xu LL, Guo QY, Cai XY, Da ZY, Zhu HQ, Zhang LY, Su Y.
    Zhonghua Nei Ke Za Zhi; 2017 Apr 01; 56(4):290-294. PubMed ID: 28355723
    [Abstract] [Full Text] [Related]

  • 15. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
    Chen YM, Lin CH, Lan TH, Chen HH, Chang SN, Chen YH, Wang JS, Hung WT, Lan JL, Chen DY.
    Rheumatology (Oxford); 2015 Jul 01; 54(7):1244-9. PubMed ID: 25587177
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoid use and abuse in SLE.
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Rheumatology (Oxford); 2012 Jul 01; 51(7):1145-53. PubMed ID: 22271756
    [Abstract] [Full Text] [Related]

  • 17. Seventy years after Hench's Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus.
    Ruiz-Irastorza G, Ugarte A, Ruiz-Arruza I, Khamashta M.
    Lupus; 2020 Sep 01; 29(10):1155-1167. PubMed ID: 32539657
    [Abstract] [Full Text] [Related]

  • 18. Prednisone in lupus nephritis: how much is enough?
    Ruiz-Irastorza G, Danza A, Perales I, Villar I, Garcia M, Delgado S, Khamashta M.
    Autoimmun Rev; 2014 Feb 01; 13(2):206-14. PubMed ID: 24189280
    [Abstract] [Full Text] [Related]

  • 19. Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort.
    Zahr ZA, Fang H, Magder LS, Petri M.
    Lupus; 2013 Jun 01; 22(7):697-701. PubMed ID: 23708944
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
    Ugarte A, Danza A, Ruiz-Irastorza G.
    Curr Opin Rheumatol; 2018 Sep 01; 30(5):482-489. PubMed ID: 29870497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.